BDBM590769 6-(4-cyanophenyl)-4-hydroxy- N-(4-methylcyclohexyl)-1-(2- morpholinoethyl)-2-oxo-1,2- dihydro-1,8-naphthyridine-3-carboxamide::US11564928, Compound 16

SMILES CC1CCC(NC(=O)c2c(O)c3cc(-c4ccc(C#N)cc4)cnc3n(CCN3CCOCC3)c2=O)CC1

InChI Key InChIKey=IOTPMIOODVDTSV-UHFFFAOYSA-N

Data  2 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 2 hits for monomerid = 590769   

TargetCannabinoid receptor 2(Human)
Teon Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 590769BDBM590769(US11564928, Compound 16 | 6-(4-cyanophenyl)-4-hydr...)
Affinity DataIC50: 22.6nMAssay Description:CB1R binding protocol involves the use of the same solution buffer used for both incubation and washing reaction (Tris-HCl, 50 mM; EDTA, 2.5 mM; MgCl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/19/2023
Entry Details
US Patent

TargetCannabinoid receptor 1(Human)
Teon Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 590769BDBM590769(US11564928, Compound 16 | 6-(4-cyanophenyl)-4-hydr...)
Affinity DataIC50: 1.00E+4nMAssay Description:CB1R binding protocol involves the use of the same solution buffer used for both incubation and washing reaction (Tris-HCl, 50 mM; EDTA, 2.5 mM; MgCl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/19/2023
Entry Details
US Patent